DE69738331D1 - Therapeutische anwendungen von laminin und von proteinfragmenten die von laminin abgeleitet sind - Google Patents

Therapeutische anwendungen von laminin und von proteinfragmenten die von laminin abgeleitet sind

Info

Publication number
DE69738331D1
DE69738331D1 DE69738331T DE69738331T DE69738331D1 DE 69738331 D1 DE69738331 D1 DE 69738331D1 DE 69738331 T DE69738331 T DE 69738331T DE 69738331 T DE69738331 T DE 69738331T DE 69738331 D1 DE69738331 D1 DE 69738331D1
Authority
DE
Germany
Prior art keywords
laminin
therapeutic applications
protein fragments
fragments derived
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69738331T
Other languages
English (en)
Other versions
DE69738331T2 (de
Inventor
Gerardo Castillo
Alan D Snow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Original Assignee
University of Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington filed Critical University of Washington
Publication of DE69738331D1 publication Critical patent/DE69738331D1/de
Application granted granted Critical
Publication of DE69738331T2 publication Critical patent/DE69738331T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69738331T 1996-10-08 1997-10-08 Therapeutische anwendungen von laminin und von proteinfragmenten die von laminin abgeleitet sind Expired - Lifetime DE69738331T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2798196P 1996-10-08 1996-10-08
US27981P 1996-10-08
PCT/US1997/018145 WO1998015179A1 (en) 1996-10-08 1997-10-08 Therapeutic and diagnostic applications of laminin and laminin-derived protein fragments

Publications (2)

Publication Number Publication Date
DE69738331D1 true DE69738331D1 (de) 2008-01-10
DE69738331T2 DE69738331T2 (de) 2008-10-16

Family

ID=21840905

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69738331T Expired - Lifetime DE69738331T2 (de) 1996-10-08 1997-10-08 Therapeutische anwendungen von laminin und von proteinfragmenten die von laminin abgeleitet sind

Country Status (7)

Country Link
US (1) US7314724B2 (de)
EP (1) EP0959682B1 (de)
AU (1) AU4749297A (de)
CA (1) CA2268029C (de)
DE (1) DE69738331T2 (de)
ES (1) ES2297852T3 (de)
WO (1) WO1998015179A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030017998A1 (en) * 1997-05-16 2003-01-23 Snow Alan D. Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
US7384910B2 (en) 1997-10-08 2008-06-10 Castillo Gerardo M Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
US6201104B1 (en) * 1998-12-04 2001-03-13 Entremed, Inc. Angiogenesis—inhibiting protein binding peptides and proteins and methods of use
DE19906096A1 (de) 1999-02-13 2000-08-17 Walter Sebald Protein mit einem Heparin-bindenden Epitop
WO2001021787A1 (en) * 1999-09-17 2001-03-29 Keio University Polypeptide humanin inhibiting nerve cell death
US20030103975A1 (en) * 1999-11-03 2003-06-05 Jones Jonathan C.R. Modulation of angiogenesis and endothelialization
US20010047032A1 (en) * 1999-12-30 2001-11-29 Castillo Gerardo M. Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
US20070208087A1 (en) 2001-11-02 2007-09-06 Sanders Virginia J Compounds, compositions and methods for the treatment of inflammatory diseases
US7829087B2 (en) 2001-07-09 2010-11-09 Elan Pharmaceuticals, Inc. Methods of treating cognitive impairment
JP4351043B2 (ja) 2001-07-09 2009-10-28 エラン ファーマシューティカルズ,インコーポレイテッド アミロイド毒性の阻害方法
DK1511710T3 (en) 2002-05-31 2014-02-24 Proteotech Inc RELATIONSHIPS, PREPARATIONS AND METHODS FOR TREATING AMYLOID DISEASES AND SYNUCLEINOPATHES, SUCH AS ALZHEIMER'S DISEASE, TYPE 2-DIABETES AND PARKINSON'S DISEASE
CA2499549C (en) * 2002-10-11 2012-01-24 Proteotech, Inc. Isolation, purification and synthesis of procyanidin b2 and uses thereof
WO2004056318A2 (en) 2002-12-19 2004-07-08 New York University Method for treating amyloid disease
CA2654008C (en) * 2006-06-01 2015-11-24 Therapeutic Peptides, Inc. Polymeric biosurfactants
SI2211851T1 (sl) * 2007-10-09 2014-11-28 Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, Reno Laminin-1 za uporabo pri izboljĺ anju regeneracije miĺ ice po poĺ kodbi ali za izboljĺ anje celjenja ran ob sistemski administraciji
FR2943062B1 (fr) * 2009-03-13 2011-04-08 Symatese Nouveau peptide promoteur de l'adhesion et de la migration cellulaire
FR2966827B1 (fr) 2010-10-27 2014-08-22 Kimonella Ventures Ltd Compose peptidique utile pour l'inhibition de la formation de plaques amyloides
US8906382B2 (en) 2011-07-19 2014-12-09 New York University Method for treating amyloid disease
WO2013012811A2 (en) 2011-07-19 2013-01-24 New York University Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
US9566310B2 (en) 2012-09-10 2017-02-14 Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno Methods of treating muscular dystrophy
US9707210B2 (en) 2013-03-15 2017-07-18 Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno Methods of treating muscular dystrophy

Also Published As

Publication number Publication date
US7314724B2 (en) 2008-01-01
EP0959682A1 (de) 1999-12-01
WO1998015179A1 (en) 1998-04-16
CA2268029A1 (en) 1998-04-16
DE69738331T2 (de) 2008-10-16
EP0959682B1 (de) 2007-11-28
US20020111309A1 (en) 2002-08-15
EP0959682A4 (de) 2003-09-03
CA2268029C (en) 2008-11-25
ES2297852T3 (es) 2008-05-01
AU4749297A (en) 1998-05-05

Similar Documents

Publication Publication Date Title
DE69738331D1 (de) Therapeutische anwendungen von laminin und von proteinfragmenten die von laminin abgeleitet sind
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
ID18320A (id) Produk obat baru dan penggunaan daripadanya
DE69813233D1 (de) Hydrocyanierung von diolefinen und isomierung von nicht-konjugierten 2-alkyl-3-monoalkennitrilen
DE69611813D1 (de) Trokar und Kanüle
DE69817015D1 (de) Gerät und methode zur wirkungsbegrenzung von detonationen
DE69736664D1 (de) Segmentierung und wiederzusammensetzung von minizellen
DE69835020D1 (de) Plasmabrenner und verwendungsverfahren dieses plasmabrenners
DE69835148D1 (de) Chirurgische clips und klemmen
DE69514715T2 (de) Konfektionierung und Vulkanisation von Reifen
DE69523791D1 (de) Peptid-mischung und produkte davon
DE69511594T2 (de) Konfektionierung und Vulkanisation von Reifen
EP1068217A4 (de) Neuartige moleküle der card-verwandten proteinfamilie und anwendungen derselben
DE69501493T2 (de) Entfernung von Feuchtigkeit und Passivierung von Oberflächen
DE69725326D1 (de) Herstellung von fugizides chinazolinonen und nützliche zwischenprodukte
GB9521544D0 (en) Activation of P53 protein and therapeutic applications thereof
DE59708905D1 (de) Injektionsformulierungen von avermectinen und milbemycinen
DE959898T1 (de) Laktoferrin varianten und verwendungen davon
DE59606486D1 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
NO965564D0 (no) Medisinsk anvendelse av bromelain
DE69841550D1 (de) Behandlung von fibromyalgie und verwandten erkrankungen
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69627515D1 (de) Material zur verleihung von nicht-klebenden und nicht-benetzenden eigenschaften
DE69717677T2 (de) Koproduktion von perfluormethylperfluorvinylether und perfluorethylperfluorvinylether
DE69702554D1 (de) Aminopeptidase GX und damit Hydrolysierungsverfahren von Proteine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition